Insurance - Life
Compare Stocks
5 / 10Stock Comparison
AFL vs UNH vs CVS vs CI vs MCK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Distribution
AFL vs UNH vs CVS vs CI vs MCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Life | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Distribution |
| Market Cap | $58.52B | $335.60B | $111.40B | $74.85B | $92.15B |
| Revenue (TTM) | $17.36B | $449.71B | $407.90B | $277.94B | $403.43B |
| Net Income (TTM) | $3.65B | $12.04B | $2.93B | $6.29B | $4.76B |
| Gross Margin | 38.7% | 18.8% | 13.9% | 9.3% | 3.6% |
| Operating Margin | 26.3% | 4.2% | 1.5% | 3.4% | 1.5% |
| Forward P/E | 15.8x | 20.2x | 12.2x | 9.4x | 19.3x |
| Total Debt | $8.41B | $78.39B | $93.59B | $31.46B | $7.39B |
| Cash & Equiv. | $6.25B | $24.36B | $8.51B | $7.68B | $5.69B |
AFL vs UNH vs CVS vs CI vs MCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aflac Incorporated (AFL) | 100 | 311.5 | +211.5% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| CVS Health Corporat… (CVS) | 100 | 133.2 | +33.2% |
| Cigna Corporation (CI) | 100 | 143.9 | +43.9% |
| McKesson Corporation (MCK) | 100 | 474.1 | +374.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AFL vs UNH vs CVS vs CI vs MCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AFL ranks third and is worth considering specifically for quality.
- 21.0% margin vs CVS's 0.7%
Among these 5 stocks, UNH doesn't own a clear edge in any measured category.
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
- 3.1% yield, vs AFL's 2.0%
- +34.7% vs CI's -13.3%
CI is the clearest fit if your priority is value.
- Lower P/E (9.4x vs 20.2x)
MCK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
- 348.1% 10Y total return vs AFL's 272.5%
- Lower volatility, beta 0.04, current ratio 0.90x
- PEG 0.49 vs AFL's 33.17
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs AFL's -8.8% | |
| Value | Lower P/E (9.4x vs 20.2x) | |
| Quality / Margins | 21.0% margin vs CVS's 0.7% | |
| Stability / Safety | Beta 0.04 vs UNH's 0.59 | |
| Dividends | 3.1% yield, vs AFL's 2.0% | |
| Momentum (1Y) | +34.7% vs CI's -13.3% | |
| Efficiency (ROA) | 5.7% ROA vs CVS's 1.1%, ROIC 5.4% vs 5.0% |
AFL vs UNH vs CVS vs CI vs MCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AFL vs UNH vs CVS vs CI vs MCK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MCK leads in 2 of 6 categories
AFL leads 1 • CI leads 1 • UNH leads 0 • CVS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AFL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 25.9x AFL's $17.4B. AFL is the more profitable business, keeping 21.0% of every revenue dollar as net income compared to CVS's 0.7%. On growth, CVS holds the edge at +6.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $17.4B | $449.7B | $407.9B | $277.9B | $403.4B |
| EBITDAEarnings before interest/tax | $5.5B | $23.2B | $10.5B | $12.1B | $6.8B |
| Net IncomeAfter-tax profit | $3.6B | $12.0B | $2.9B | $6.3B | $4.8B |
| Free Cash FlowCash after capex | $2.6B | $19.7B | $7.4B | $7.7B | $6.0B |
| Gross MarginGross profit ÷ Revenue | +38.7% | +18.8% | +13.9% | +9.3% | +3.6% |
| Operating MarginEBIT ÷ Revenue | +26.3% | +4.2% | +1.5% | +3.4% | +1.5% |
| Net MarginNet income ÷ Revenue | +21.0% | +2.7% | +0.7% | +2.3% | +1.2% |
| FCF MarginFCF ÷ Revenue | +14.7% | +4.4% | +1.8% | +2.8% | +1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.9% | +2.0% | +6.2% | +4.6% | +6.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.3% | +0.7% | +63.1% | +29.1% | +37.0% |
Valuation Metrics
CI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.8x trailing earnings, CI trades at a 80% valuation discount to CVS's 62.8x P/E. Adjusting for growth (PEG ratio), MCK offers better value at 0.75x vs AFL's 33.17x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $58.5B | $335.6B | $111.4B | $74.9B | $92.1B |
| Enterprise ValueMkt cap + debt − cash | $60.7B | $389.6B | $196.5B | $98.6B | $93.8B |
| Trailing P/EPrice ÷ TTM EPS | 16.63x | 27.95x | 62.81x | 12.81x | 29.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.76x | 20.19x | 12.19x | 9.36x | 19.28x |
| PEG RatioP/E ÷ EPS growth rate | 33.17x | — | — | — | 0.75x |
| EV / EBITDAEnterprise value multiple | 11.00x | 16.70x | 13.11x | 8.39x | 18.74x |
| Price / SalesMarket cap ÷ Revenue | 3.36x | 0.75x | 0.28x | 0.27x | 0.26x |
| Price / BookPrice ÷ Book value/share | 2.05x | 3.31x | 1.47x | 1.80x | — |
| Price / FCFMarket cap ÷ FCF | 22.90x | 20.88x | 14.27x | 8.92x | 17.63x |
Profitability & Efficiency
MCK leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $4 for CVS. AFL carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), CI scores 8/9 vs AFL's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.1% | +11.5% | +3.9% | +15.1% | +3.0% |
| ROA (TTM)Return on assets | +3.0% | +3.9% | +1.1% | +4.1% | +5.7% |
| ROICReturn on invested capital | +11.8% | +9.2% | +5.0% | +10.4% | +5.4% |
| ROCEReturn on capital employed | +4.0% | +9.7% | +6.1% | +9.2% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.29x | 0.77x | 1.24x | 0.75x | — |
| Net DebtTotal debt minus cash | $2.2B | $54.0B | $85.1B | $23.8B | $1.7B |
| Cash & Equiv.Liquid assets | $6.2B | $24.4B | $8.5B | $7.7B | $5.7B |
| Total DebtShort + long-term debt | $8.4B | $78.4B | $93.6B | $31.5B | $7.4B |
| Interest CoverageEBIT ÷ Interest expense | 21.00x | 4.71x | 2.11x | 6.77x | 33.79x |
Total Returns (Dividends Reinvested)
MCK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $9,743 for UNH. Over the past 12 months, CVS leads with a +34.7% total return vs CI's -13.3%. The 3-year compound annual growth rate (CAGR) favors MCK at 27.3% vs UNH's -7.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.6% | +10.6% | +10.6% | +2.3% | -8.5% |
| 1-Year ReturnPast 12 months | +8.4% | -3.2% | +34.7% | -13.3% | +4.6% |
| 3-Year ReturnCumulative with dividends | +77.1% | -19.9% | +36.6% | +13.6% | +106.4% |
| 5-Year ReturnCumulative with dividends | +118.8% | -2.6% | +17.0% | +18.5% | +286.9% |
| 10-Year ReturnCumulative with dividends | +272.5% | +220.6% | +3.5% | +136.5% | +348.1% |
| CAGR (3Y)Annualised 3-year return | +21.0% | -7.1% | +11.0% | +4.4% | +27.3% |
Risk & Volatility
Evenly matched — CVS and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs MCK's 75.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.19x | 0.59x | 0.05x | 0.35x | 0.04x |
| 52-Week HighHighest price in past year | $119.32 | $395.52 | $88.63 | $338.89 | $999.00 |
| 52-Week LowLowest price in past year | $96.95 | $234.60 | $58.35 | $239.51 | $637.00 |
| % of 52W HighCurrent price vs 52-week peak | +95.2% | +93.5% | +98.5% | +83.8% | +75.3% |
| RSI (14)Momentum oscillator 0–100 | 51.0 | 75.9 | 69.3 | 53.5 | 16.2 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 7.9M | 7.4M | 1.5M | 757K |
Analyst Outlook
Evenly matched — AFL and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AFL as "Hold", UNH as "Buy", CVS as "Buy", CI as "Buy", MCK as "Buy". Consensus price targets imply 33.8% upside for MCK (target: $1007) vs -2.4% for AFL (target: $111). For income investors, CVS offers the higher dividend yield at 3.06% vs MCK's 0.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $110.83 | $385.43 | $95.20 | $328.00 | $1006.50 |
| # AnalystsCovering analysts | 32 | 52 | 41 | 39 | 31 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +2.4% | +3.1% | +2.1% | +0.4% |
| Dividend StreakConsecutive years of raises | 37 | 25 | 0 | 6 | 17 |
| Dividend / ShareAnnual DPS | $2.25 | $8.70 | $2.67 | $6.06 | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.0% | +1.7% | 0.0% | +4.8% | +3.4% |
MCK leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). AFL leads in 1 (Income & Cash Flow). 2 tied.
AFL vs UNH vs CVS vs CI vs MCK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AFL or UNH or CVS or CI or MCK a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus -8. 8% for Aflac Incorporated (AFL). Cigna Corporation (CI) offers the better valuation at 12. 8x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AFL or UNH or CVS or CI or MCK?
On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.
8x versus CVS Health Corporation at 62. 8x. On forward P/E, Cigna Corporation is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 49x versus Aflac Incorporated's 33. 17x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AFL or UNH or CVS or CI or MCK?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.
9%, compared to -2. 6% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: MCK returned +348. 1% versus CVS's +3. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AFL or UNH or CVS or CI or MCK?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1261% more volatile than MCK relative to the S&P 500. On balance sheet safety, Aflac Incorporated (AFL) carries a lower debt/equity ratio of 29% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AFL or UNH or CVS or CI or MCK?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus -8. 8% for Aflac Incorporated (AFL). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AFL or UNH or CVS or CI or MCK?
Aflac Incorporated (AFL) is the more profitable company, earning 20.
9% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 20. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AFL leads at 26. 6% versus 1. 2% for MCK. At the gross margin level — before operating expenses — AFL leads at 38. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AFL or UNH or CVS or CI or MCK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 49x versus Aflac Incorporated's 33. 17x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cigna Corporation (CI) trades at 9. 4x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 33. 8% to $1006. 50.
08Which pays a better dividend — AFL or UNH or CVS or CI or MCK?
All stocks in this comparison pay dividends.
CVS Health Corporation (CVS) offers the highest yield at 3. 1%, versus 0. 4% for McKesson Corporation (MCK).
09Is AFL or UNH or CVS or CI or MCK better for a retirement portfolio?
For long-horizon retirement investors, Aflac Incorporated (AFL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
19), 2. 0% yield, +272. 5% 10Y return). Both have compounded well over 10 years (AFL: +272. 5%, UNH: +220. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AFL and UNH and CVS and CI and MCK?
These companies operate in different sectors (AFL (Financial Services) and UNH (Healthcare) and CVS (Healthcare) and CI (Healthcare) and MCK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AFL is a mid-cap deep-value stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; CI is a mid-cap deep-value stock; MCK is a mid-cap high-growth stock. AFL, UNH, CVS, CI pay a dividend while MCK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.